222 related articles for article (PubMed ID: 15598963)
1. Rifaximin: a new treatment for travelers' diarrhea.
Pakyz AL
Ann Pharmacother; 2005 Feb; 39(2):284-9. PubMed ID: 15598963
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
DuPont HL; Ericsson CD; Mathewson JJ; Palazzini E; DuPont MW; Jiang ZD; Mosavi A; de la Cabada FJ
Digestion; 1998; 59(6):708-14. PubMed ID: 9813398
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin treatment of pathogen-negative travelers' diarrhea.
DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R
J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
6. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Dupont HL; Jiang ZD; Belkind-Gerson J; Okhuysen PC; Ericsson CD; Ke S; Huang DB; Dupont MW; Adachi JA; De La Cabada FJ; Taylor DN; Jaini S; Martinez Sandoval F
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):451-6. PubMed ID: 17382603
[TBL] [Abstract][Full Text] [Related]
7. Therapy of travelers' diarrhea with rifaximin on various continents.
Steffen R; Sack DA; Riopel L; Jiang ZD; Stürchler M; Ericsson CD; Lowe B; Waiyaki P; White M; DuPont HL
Am J Gastroenterol; 2003 May; 98(5):1073-8. PubMed ID: 12809830
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin: a nonabsorbed oral antibiotic.
Baker DE
Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
[TBL] [Abstract][Full Text] [Related]
9. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618
[TBL] [Abstract][Full Text] [Related]
10. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.
Cottreau J; Baker SF; DuPont HL; Garey KW
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):747-60. PubMed ID: 20586560
[TBL] [Abstract][Full Text] [Related]
11. Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.
Riddle MS; Connor P; Fraser J; Porter CK; Swierczewski B; Hutley EJ; Danboise B; Simons MP; Hulseberg C; Lalani T; Gutierrez RL; Tribble DR;
Clin Infect Dis; 2017 Nov; 65(12):2008-2017. PubMed ID: 29029033
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL; DuPont HL
Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Hu Y; Ren J; Zhan M; Li W; Dai H
J Travel Med; 2012 Dec; 19(6):352-6. PubMed ID: 23379704
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin (Xifaxan) for travelers' diarrhea.
Med Lett Drugs Ther; 2004 Sep; 46(1191):74-5. PubMed ID: 15365508
[No Abstract] [Full Text] [Related]
15. Rifaximin: new therapeutic indication and future directions.
Rivkin A; Gim S
Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
[TBL] [Abstract][Full Text] [Related]
16. Rifamycin (Aemcolo) for treatment of travelers' diarrhea.
Med Lett Drugs Ther; 2019 Mar; 61(1567):39-40. PubMed ID: 30845098
[No Abstract] [Full Text] [Related]
17. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
DuPont HL; Jiang ZD; Ericsson CD; Adachi JA; Mathewson JJ; DuPont MW; Palazzini E; Riopel LM; Ashley D; Martinez-Sandoval F
Clin Infect Dis; 2001 Dec; 33(11):1807-15. PubMed ID: 11692292
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.
Steffen R
J Travel Med; 2001 Dec; 8(Suppl 2):S34-9. PubMed ID: 12186672
[No Abstract] [Full Text] [Related]
19. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.
Koo HL; Dupont HL; Huang DB
Ther Clin Risk Manag; 2009; 5():841-8. PubMed ID: 19898648
[TBL] [Abstract][Full Text] [Related]
20. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
